AC
IRWD icon

Athanor Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Athanor Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-45,833
Closed -$512K – 594
2021
Q1 		$512K Sell
45,833
-20,201
-31% -$213K 0.01% 473
2020
Q4 		$752K Sell
66,034
-37,588
-36% -$411K 0.02% 377
2020
Q3 		$932K Buy
103,622
+23,749
+30% +$236K 0.04% 249
2020
Q2 		$824K Buy
+79,873
New +$817K 0.04% 223

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Athanor Capital's IRWD Position: Q2 2021 in Review

Athanor Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2021, closing a stake of 45,833 shares — an estimated $512K sold.

Athanor Capital first reported a position in IRWD in Q2 2020 and held it in 4 quarters. The position peaked at $932K in Q3 2020. 208 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

  • Athanor Capital reported no remaining Ironwood Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 45,833 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $512K.
  • Athanor Capital first reported a position in Ironwood Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Athanor Capital's Ironwood Pharmaceuticals position peaked at $932K in Q3 2020.
  • 208 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.